ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,398 | -35.1% | 14,776 | 0.0% | 0.00% | – |
| Q1 2023 | $5,237 | -2.7% | 14,776 | -11.9% | 0.00% | – |
| Q4 2022 | $5,383 | -55.1% | 16,776 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -20.0% | 16,776 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -40.0% | 16,776 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -55.4% | 16,776 | +6.5% | 0.00% | – |
| Q3 2021 | $56,000 | – | 15,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
| BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
| PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
| P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
| Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
| EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
| Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
| Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |